L. Jeffers

发表

Peginterferon alfa‐2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response

K. Reddy, C. Howell, L. Jeffers, 2006, Journal of viral hepatitis.

Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection

H. Yang, H. Erlich, J. Li, 2008, Genes and Immunity.

Use of recombinant HCV antigen in the serodiagnosis of hepatitis C virus infection: Significant improvement in HCV antibody detection as compared with the first generation HCV C100‐3 ELISA and the synthetic peptide EIA tests

Q. Choo, J. Shuster, H. Alter, 1993 .

Early graft loss secondary to massive hemorrhagic necrosis following orthotopic liver transplantation. Evidence for cytokine-mediated univisceral Shwartzman reaction.

E. Schiff, P. Ruiz, A. Tzakis, 1996, Transplantation.

Liver transplantation for cirrhosis following jejuno-ileal bypass--regional cytokine differences associated with pathological changes in the transplant liver.

E. Schiff, G. Burke, Joshua Miller, 1992, Transplantation.

Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses.

E. Schiff, G. Reyes, M. Silva, 1993, Gastroenterology.

Antiviral efficacy of entecavir in nucleos(t)ide‐naïve patients of Black/African descent with chronic hepatitis B

M. Schechter, R. Paraná, C. Llamoso, 2014, Journal of viral hepatitis.

The significance of hepatitis G virus in serum of patients with sporadic fulminant and subfulminant hepatitis of unknown etiology.

E. Schiff, A. Reid, T. Liang, 1999, Blood.

Activated cytokine pattern in hepatorenal syndrome: fall in levels after successful orthotopic liver transplantation.

E. Schiff, G. Burke, D. Roth, 1993, Transplantation proceedings.

Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma-A phase II trial

E. Schiff, N. Savaraj, L. Feun, 2003, Journal of Cancer Research and Clinical Oncology.